Arctoris
Tech-enabled partnership research organisation
- 21-100 employees
- Healthcare
- B2B
- Enterprise
- Robotics
- Milton, UK
Jump to section
Company mission
To use robotics to provide drug discovery data on demand for researchers in biotech, pharma and academia.
55% employee growth in 12 months
Our take
Founded in 2015, Arctoris has grown from a technology startup to a globally operating company delivering integrated drug discovery projects. It provides drug discovery companies, pharmaceutical corporations and academic centres with fully automated Experiments-as-a-Service powered by robotics. This allows Arctoris to accelerate innovation and speed up the drug discovery process.
The drug discovery ecosystem is evolving rapidly, and the key to success is having access to the right data at the right time, to progress the right projects toward the clinic. Arctoris plays a vital role in enabling true data-driven drug discovery and the company set itself apart being the world’s first fully automated R&D platform dedicated to drug discovery.
Arctoris has partners on three continents from its headquarters in Oxford and its Asia-Pacific hub in Singapore. Arctoris will be focused on developing the proprietary technology behind its robots, expanding its service offering, hiring top talent and building a new laboratory facility.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Fuel Your Growth: Access a world of learning through our in-house and external courses, expert mentors and coaches to help you grow, lead and thrive.
- Wellbeing, Growth & Rewards: From competitive salaries to health, dental, pension, and life insurance, our benefits are designed to support you and your loved ones.
- Flexibility That Lets You Thrive: We offer flexible, hybrid work options and a family-friendly culture, with enhanced benefits, so you can do your best work.
- A Collaborative and Diverse Community: Join employee-led groups from LGBT+ teammates, women in tech, parents, pets, books and more - ensuring everyone has a voice, and a path to thrive.
Funding (last 2 of 8 rounds)
Dec 2025
$2.8m
EARLY VC
Feb 2021
$0.7m
GRANT
Total funding: $13.3m
Leadership
Tom Fleming
(Co-Founder, CEO & Executive Director)Tom is also the Founder of Crucible Consulting where they serve as a Principal Advisor.